IL-33 improved Alzheimer's disease-like pathology modulating IL-1β, IL-6, and NLR family pyrin domain containing 3 (NLRP3) genes in the cortices of APP/PS1 mice and decreasing cognitive impairment [39]. Here, IL33 is linked to Alzheimer disease.